Abstract
Clinical outcome in ovarian carcinoma is predicted by progesterone receptor status, indicating an endocrine aspect to this disease. Peripheral leucocyte genomic DNAs were obtained from 41 patients with primary ovarian carcinoma and 83 controls from Ireland, as well as from 26 primary ovarian carcinoma patients and 101 controls in Germany. Southern analysis using a human progesterone receptor (hPR) cDNA probe identified a germline TaqI restriction fragment length polymorphism (RFLP) defined by two alleles: T1, represented by a 2.7 kb fragment; and T2, represented by a 1.9 kb fragment and characterised by an additional TaqI restriction site with respect to T1. An over-representation of T2 in ovarian cancer patients compared with controls in the pooled Irish/German population (P < 0.025) was observed. A difference (P < 0.02) in the distribution of the RFLP genotypes between Irish and German control populations was also observed. The allele distributions could not be shown to differ significantly from Hardy-Weinberg distribution in any subgroup. Using hPR cDNA region-specific probes, the extra TaqI restriction site was mapped to intron G of the hPR gene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McKenna, N., Kieback, D., Carney, D. et al. A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. Br J Cancer 71, 451–455 (1995). https://doi.org/10.1038/bjc.1995.92
Issue Date:
DOI: https://doi.org/10.1038/bjc.1995.92
This article is cited by
-
Progesterone Receptor Gene Variants in Metastatic Estrogen Receptor Positive Breast Cancer
Hormones and Cancer (2020)
-
Association of the progesterone receptor gene polymorphism (PROGINS) with endometriosis: a meta-analysis
Archives of Gynecology and Obstetrics (2014)
-
Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies
Tumor Biology (2014)
-
Effects of PGR and ESRα genotypes on the pregnancy rates after embryo transfer in Luxi cattle
Molecular Biology Reports (2013)
-
Analyze association of the progesterone receptor gene polymorphism PROGINS with ovarian cancer risk
Molecular Biology Reports (2013)